Literature DB >> 6279102

Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities.

P M Keller, J A Fyfe, L Beauchamp, C M Lubbers, P A Furman, H J Schaeffer, G B Elion.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6279102     DOI： 10.1016/0006-2952(81)90495-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  25 in total

1.  Improved synthesis of 2'-deoxy-2'-[18F]-fluoro-1-beta-D-arabinofuranosyl-5-iodouracil ([18F]-FIAU).

Authors:  Harry Anderson; Nagavarakishore Pillarsetty; Melchor Cantorias; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2010-03-06       Impact factor: 2.408

2.  Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy.

Authors:  G B Elion
Journal:  In Vitro Cell Dev Biol       Date:  1989-04

3.  Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.

Authors:  M N Ellis; P M Keller; J A Fyfe; J L Martin; J F Rooney; S E Straus; S N Lehrman; D W Barry
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

Review 4.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

5.  A transferred NOE study of a tricyclic analog of acyclovir bound to thymidine kinase.

Authors:  J Czaplicki; T Bohner; A K Habermann; G Folkers; A Milon
Journal:  J Biomol NMR       Date:  1996-10       Impact factor: 2.835

6.  Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase.

Authors:  A R Karlström; C F Källander; G Abele; A Larsson
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

7.  Comparison of polymorphism of thymidine kinase gene and restriction fragment length polymorphism of genomic DNA in herpes simplex virus type 1.

Authors:  M Nagamine; T Suzutani; M Saijo; K Hayashi; M Azuma
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

8.  Conformational aspects of antiviral activity of deoxyguanosine acyclic analogues.

Authors:  A A Golbraikh; J Betins; J Balodis; R A Zhuk; G V Nikiforovich
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

9.  The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation.

Authors:  Moira A McMahon; Janet D Siliciano; Jun Lai; Jun O Liu; James T Stivers; Robert F Siliciano; Rahul M Kohli
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

10.  Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment.

Authors:  G B Roberts; J A Fyfe; R K Gaillard; S A Short
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.